Screening for Chronic Kidney Disease: Preventing Harm or Harming the Healthy?

PLoS Medicine

Volumn 9, Issue 11, 2012, Pages

  Taal, Maarten W ^a  

^a ROYAL DERBY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CREATININE; CYSTATIN C; RENIN INHIBITOR;

ALBUMINURIA; ARTICLE; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HOSPITALIZATION COST; HUMAN; HYPERTENSION; PROGNOSIS; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

DISEASE PROGRESSION; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT;

EID: 84870256753     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001345     Document Type: Article

References (20)

1. Moynihan R, Doust J, Henry D, (2012) Preventing overdiagnosis: how to stop harming the healthy. BMJ 344: 19-23.
2. Echouffo-Tcheugui JB, Kegne AP, (2012) Risk models to predict chronic kidney disease and its progression: A systematic review. PLoS Med 9 (11) (): e1001344 doi:10.1371/journal.pmed.1001344.
3. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS, (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12.
4. Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, et al. (2011) Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 79: 1331-1340.
5. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, et al. (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes in both general and high-risk populations. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80: 93-104.
6. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-2081.
7. Mahmoodi BK, Gansevoort RT, Naess IA, Lutsey PL, Braekkan SK, et al. (2012) Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation 126: 1964-1971.
8. Kidney Disease Outcomes Quality Initiative (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266.
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
10. Winearls CG, Glassock RJ, (2009) Dissecting and refining the staging of chronic kidney disease. Kidney Int 75: 1009-1014.
11. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
12. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, et al. (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29.
13. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, et al. (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348: 2285-2293.
14. Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC, (2006) Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev pp. CD006257.
15. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, et al. (2001) Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Int Med 135: 73-87.
16. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, et al. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New Engl J Med 345: 861-869.
17. Brouwers FP, Asselbergs FW, Hillege HL, de Boer RA, Gansevoort RT, et al. (2011) Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT). Am Heart J 161: 1171-1178.
18. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, et al. (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377: 2181-2192.
19. Moyer VA, (2012) Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157: 567-570.
20. National Institute for Health and Clinical Excellence (2008) Chronic kidney disease: national clinical guideline for early identification and management of chronic kidney disease in adults in primary and secondary care. Available: http://www.nice.org.uk/cg73. Accessed September 2012.